Logo Image
News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsEventsSponsored PodcastsSponsored VideosWebcastsWhitepaperseBooks
Event Calendar

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Event Calendar
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement

Adam Nelson

Advertisement

Articles by Adam Nelson

How Pharmas, Payers, and Providers Can Meet the ‘Triple Aim’

ByAdam Nelson
October 17th 2017

Today’s model requires a fourth partner-the systems integrator

Advertisement

Latest Updated Articles

  • How Pharmas, Payers, and Providers Can Meet the ‘Triple Aim’
    How Pharmas, Payers, and Providers Can Meet the ‘Triple Aim’

    October 17th 2017



Advertisement
Advertisement

Trending on PharmExec

1

EMA Panel Backs Lilly’s Foundayo for Obesity and Type 2 Diabetes in Europe

2

FDA Approves Enspryng (Satralizumab) for Thyroid Eye Disease

3

The Bubble You Don’t Know You’re In: A Three-Part Series on The Medical Benefit Bubble

4

The Unique Considerations Mid-Sized Pharma Companies Face When Making MFN Deals

5

Domestic Manufacturing Is a Meaningful But Incomplete Answer

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us